Literature DB >> 10996221

Involvement of CD70-CD27 interactions in the induction of experimental autoimmune encephalomyelitis.

A Nakajima1, H Oshima, C Nohara, S Morimoto, S Yoshino, T Kobata, H Yagita, K Okumura.   

Abstract

CD70/CD27 are cell surface molecules belonging to the TNF/TNF-receptor families. Ligation of CD27 by its ligand CD70 is thought to be important in T cell activation and T cell-B cell interaction. However, the in vivo function of these molecules during the establishment of cell-mediated immunity remains unclear. In this study, we examined the contribution of CD70-CD27 interactions to cell-mediated immunity by investigating the effect of anti-CD70 mAb on the development of experimental autoimmune encephalomyelitis (EAE). Treatment of SJL/J mice with anti-CD70 mAb prevented EAE induced by immunization with PLP(139-151). The preventive effect of anti-CD70 mAb was not due to the inhibition of T cell priming and antibody production from B cells, or immune deviation. However, TNF-alpha production was suppressed by treatment with anti-CD70 mAb, indicating that the ameliorating effect of anti-CD70 mAb appeared, at least in part, to be mediated by the inhibition of TNF-alpha production. These results indicate that the CD70-CD27 interaction plays a pivotal role in the development of cell-mediated autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996221     DOI: 10.1016/s0165-5728(00)00324-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.

Authors:  Nicholas D Leigh; Rachel E O'Neill; Wei Du; Chuan Chen; Jingxin Qiu; Jonathan D Ashwell; Philip L McCarthy; George L Chen; Xuefang Cao
Journal:  J Immunol       Date:  2017-05-26       Impact factor: 5.422

2.  The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.

Authors:  D S Vinay; B S Kwon
Journal:  Clin Exp Immunol       Date:  2011-03-14       Impact factor: 4.330

Review 3.  Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Authors:  Qianxia Zhang; Dario A A Vignali
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

4.  The CD70-CD27 axis, a new brake in the T helper 17 cell response.

Authors:  Xiaohu Wang; Chen Dong
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

5.  CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus.

Authors:  Ivana Munitic; Mirela Kuka; Atef Allam; Jonathan P Scoville; Jonathan D Ashwell
Journal:  J Immunol       Date:  2012-12-26       Impact factor: 5.422

6.  Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis.

Authors:  Monika Manocha; Svend Rietdijk; Rietdijk Svend; Amale Laouar; Gongxian Liao; Atul Bhan; Jannie Borst; Jannine Borst; Cox Terhorst; N Manjunath
Journal:  J Immunol       Date:  2009-06-12       Impact factor: 5.422

Review 7.  The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.

Authors:  Ricardo F Antunes; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  J Biomed Biotechnol       Date:  2011-12-22

8.  The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.

Authors:  Françoise Meylan; Todd S Davidson; Erin Kahle; Michelle Kinder; Krishika Acharya; Dragana Jankovic; Virgilio Bundoc; Marcus Hodges; Ethan M Shevach; Andrea Keane-Myers; Eddie C Y Wang; Richard M Siegel
Journal:  Immunity       Date:  2008-06-19       Impact factor: 31.745

Review 9.  T-cell co-stimulatory pathways in autoimmunity.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Res Ther       Date:  2008-10-15       Impact factor: 5.156

Review 10.  Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.

Authors:  Sandip Sonar; Girdhari Lal
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.